{"name":"EPS Corporation","slug":"eps-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNZlVHaXpVWGJiTDdiNnlROXUzTmVWek5CTWQwLUlDUnNWMnZZNl91MEEwZ0lPVnU1N1VUTjkzQmtGMEZwemlzNzNZTXpNRWdjVzhxU3g0Z2hVOEkxWk9mc2RZVDA5OEpOTFY1aVA2OUFIbmZHZGdvTTNyVVZHY244V2VwWF9ySFRZUDVXZDdnYWlFSkxUb1pyTWNnNA?oc=5","date":"2026-02-23","type":"pipeline","source":"Finviz","summary":"Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7% - Finviz","headline":"Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQZkZxX2dqZmY0eFBnSm50WnlwYUlZckVOM3IzYk1zSWd6SVU4YUVhYW8zeFdna0s2MWI0S25FTFJUUUo4ZDNzSTY0QW1QR25ROURZeUdRTkgwWlRMeVFEcGthSHRqS0kwSUpXcDlqc1NqTlpDdGxkV3NQZ0FDODdEamJmOGl3N19sRUtfazRxdF9lR2QwdDRYUzhFLU5TeXZ3MkI1Tm9QS0hHbHNNVkJOZk9EX1NMbmZNZEM4TzBDOXJJSTcwM3F0Q3ZSUk5jbTNV?oc=5","date":"2026-02-19","type":"earnings","source":"Investing.com","summary":"Earnings call transcript: Madrigal Pharmaceuticals Q4 2025 misses EPS, stock dips - Investing.com","headline":"Earnings call transcript: Madrigal Pharmaceuticals Q4 2025 misses EPS, stock dips","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQcXlpc1h3XzFfTTkxWU13aUljc3VFVGFZRXk3WXg5YkxLMHJKM3NBTkxOM3hTeTBESU82N1lBY3pPYU1TR0xxcHM3eXNiYVgxNjlxaE5UaFFrSndSeU41Q2tkSmpheVFGMXh1cU9DSHptZE1hV2M0VFFqbmlHU1RMNUEtU1IzY0JpT1BvQnhkMjRzMWhlUU1BM05qbnhvQ2ZTbGZtb1dYcVV1d1E5MkRfYk83dzJldWpJMm5yWg?oc=5","date":"2026-02-12","type":"earnings","source":"TradingView","summary":"WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up - TradingView","headline":"WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPLTZRUUM1TmpoTWFJeW1JeXZWRmRlM3VtcVVrY2dZWmdFbGR6TDZ5dEtnTFVXNWxCV2JKVGQ1Z0FjQTZpU0pTdjBiSDg1ZEZuUGExRjA3a2xHMXBqMElqZXdyUGVIV2lWS0N3Q1BaQXdJOExYc1pzZVNwbk1BU3pBbmswQTR3ZkRwaUFIUTdKVW81TWFSLVg1cDFwdEUtSzRkOEpQU0JRQXk1a2tIUk1ITHJ2Yw?oc=5","date":"2026-02-05","type":"earnings","source":"TradingView","summary":"CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains - TradingView","headline":"CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQZDNrLVVLcWJYcWY5ZUxma0FBZUJiTU5OWG96Q3g5bTZLRDlkczRDVTBQeXhjdHVCdzZEME9TQ2FWQk84bHRTRFprSjZ3Sm4tdTZCYkotUUtBcEtqbV9RdUFRUm1abHFpbU9oc0JTaTA3VUVrNy1jVTcwWTFHU1NNbGlwSGI4WUJKellxOTVkbU5XalEzS21YdkU5WTB2UE1NeFp1TGxWMHlpa2phM0hlckRzTUxhcEhhUlZJei0tcjdJM19vbEV1ZGNUZ0UzY3AxNG1rSndsbno1TFExVmNQY043X3JQM01lSGpkMUZR?oc=5","date":"2026-02-04","type":"earnings","source":"Whalesbook","summary":"Shukra Pharma Skyrockets Revenue 270%, Profit 542%, But EPS Dips - Whalesbook","headline":"Shukra Pharma Skyrockets Revenue 270%, Profit 542%, But EPS Dips","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOUHZqdTlrZ19lRFU1eTlva01mcG1wUXI0Rmw3eml4Mm1jZFUwb2liYk9iajNGcXAwdGVDUk1PY0U4RDZaekkwQnJnUnZadWpsWkVoMHhUZGl3aFNUWTdrT25HQ25CcnV2OEVLQzdMNlc5TGJHc2V0aWpfSVR2LXVBU0tXZGdQenVGcWFpM1hObw?oc=5","date":"2026-01-31","type":"earnings","source":"Yahoo Finance","summary":"Regeneron Pharmaceuticals, Inc. (REGN) Posts Q4 Earnings Beat, EPS Shines - Yahoo Finance","headline":"Regeneron Pharmaceuticals, Inc. (REGN) Posts Q4 Earnings Beat, EPS Shines","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNLTNEVkJ2d1BnaVJvLTFqeHk0V3FrS0oxRmVLY29kMEtMUUY4ZG5ubG5fUnFORHpUQnRiTlFWQlVrT05kQm1EVW1hcV9BUnNOMWhUcDJzUXBCSjdQZ0RYWkRVeEN5OHU5MHRQQ2RxM3dyTS1XbUQxUkdMR2xIYVZINXFlMzhuQVQtNTZHOU1RVDRHYTlWQWtselRNZy1qZzN5VVdBSEhkZk54TGlpNVltVWFodW84aTE5?oc=5","date":"2025-12-18","type":"pipeline","source":"PR Newswire","summary":"EPS Corporation Selects ArisGlobal's LifeSphere® MultiVigilance - PR Newswire","headline":"EPS Corporation Selects ArisGlobal's LifeSphere® MultiVigilance","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-30","type":"earnings","source":"simplywall.st","summary":"Earnings Miss: BioMarin Pharmaceutical Inc. Missed EPS And Analysts Are Revising Their Forecasts - simplywall.st","headline":"Earnings Miss: BioMarin Pharmaceutical Inc. Missed EPS And Analysts Are Revising Their Forecasts","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPejJ6RFJ4SmlTZmphWW9YeGxmYTRyX2ZjRmF5ZjlydjRMd3RrYW9jb3lNTHJyN1VGc0pOa0djeXpNODVFSV9SOE40dEM1YTFpRWs3aXZfMnphSlBPNERkNXhhQmNJLTBiZ19pRDMzNkdjVDBzUFROWmU5Mjh2QmxBZmZsTlJfRUdRUTE0Z2l3Y2F2X1ZUNVZzcXBkb2pzTEoyT0pLTGt0TUpkV0pnUGVubDhoMld4d1hhMEdScUxxSlNyVUpoVGxmY0lIOUs4bmJh?oc=5","date":"2025-08-05","type":"earnings","source":"Business Wire","summary":"Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance - Business Wire","headline":"Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPMm9LenNHZllERTJIdUQ5VDVBeXhiekFfWW91OVNRNUd3d1R0cjhKMWZfekVLYlkzYmEyTTF2OFUzQUZiMUVYUXY3S2d4LVZKc1dxaHhJSTRmSElCaHk4NER3c2pTMmpMZWJCLV9lbGNhY1ZoQ1hhcWZFcFp4N2c2LUJBaXp0cm9TUEZIU2V3?oc=5","date":"2025-08-03","type":"pipeline","source":"Yahoo Finance","summary":"Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Just Beat EPS By 9.1%: Here's What Analysts Are Forecasting For This Year - Yahoo Finance","headline":"Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Just Beat EPS By 9.1%: Here's What Analysts Are Forecasting For This Year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNS0pQRDdQc3hTTmZhU0JzNGJZay16ZXJMbmRiN3lCVTRJcWFVZG92V3pPeXgybGVWVk5RUmdSVWdIZ0s0SzhfX0s4UmJqX2FxZGpxRUd1Um53RVBrNEpDNkRncjRjVnZkOGFtOUZSR1VJUnRheWpmSXhJc3Blcm4zLXRRZjNBZ2ZUdC04VW5OMmhHdEluNF9OX09hWUM3Q182dWtzRW1QMG5UV2g5a25RWkRlUGI4M1E5YUs5NjBEVWVWbWdLNDFRdml3SlpEalhSem5fdG9lYkVrN0FRNkthSTBRbWdIMlVw?oc=5","date":"2025-07-23","type":"earnings","source":"Investing.com","summary":"Cipher Pharmaceuticals Q1 2025 slides: Natroba acquisition drives revenue growth despite EPS miss - Investing.com","headline":"Cipher Pharmaceuticals Q1 2025 slides: Natroba acquisition drives revenue growth despite EPS miss","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOcWZfR0ROWmtCaHc0LXhNOUhOeG53enZSbWFVVHlaMDQ4dUxIdTNpdWRtWDNXMnJlSklpUEctTDNFTS1FWlh1bFJzWllqLXpqcmdDMEtBaTg4dDJlYW00MTBQSUVvTVBCYWg2UjZnelE0UDNtMXRlRmRIQ0tSX1MzTkVFdEJETzNoQmxaa1JFR25vOEFLOHhUbU9ydjEyd3lfak9fU1JvNVNMNGFudG9rSGxGSjFfaXpXS3M3MFlfS0U5Z3ZFVUZv?oc=5","date":"2025-02-28","type":"pipeline","source":"BioSpace","summary":"Pharmaceutical Contract Sales Organizations Market Size to Hit USD 26.24 Billion by 2034 - BioSpace","headline":"Pharmaceutical Contract Sales Organizations Market Size to Hit USD 26.24 Billion by 2034","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}